Gina Mazzariello
General Counsel bei AMYLYX PHARMACEUTICALS, INC.
Vermögen: 459 887 $ am 31.03.2024
Profil
Gina M.
Mazzariello is currently the Chief Legal Officer & General Counsel at Amylyx Pharmaceuticals, Inc. She previously worked as the Chairman at Lawyers Collaborative for Diversity, Inc. and as the Vice President-Human Pharma Business Law at Boehringer Ingelheim Pharmaceuticals, Inc. Mazzariello received her undergraduate degree from Syracuse University and her graduate degree from Harvard Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2024 | 161 932 ( 0,24% ) | 459 887 $ | 31.03.2024 |
Aktive Positionen von Gina Mazzariello
| Unternehmen | Position | Beginn |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | General Counsel | 23.02.2022 |
Ehemalige bekannte Positionen von Gina Mazzariello
| Unternehmen | Position | Ende |
|---|---|---|
Lawyers Collaborative for Diversity, Inc.
 Lawyers Collaborative for Diversity, Inc. Miscellaneous Commercial ServicesCommercial Services Lawyers Collaborative for Diversity, Inc. operates as a nonprofit organization that was formed by lawyers committed to advancing diversity in the legal profession. It helps to unite the resources, energy and commitment of the state’s leading law firms, corporations, public sector entities, law schools, state and county bar associations and affinity bar organizations. The company was founded in 2003 and is headquartered in Hartford, CT. | Chairman | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Ausbildung von Gina Mazzariello
| Syracuse University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Lawyers Collaborative for Diversity, Inc.
Lawyers Collaborative for Diversity, Inc. Miscellaneous Commercial ServicesCommercial Services Lawyers Collaborative for Diversity, Inc. operates as a nonprofit organization that was formed by lawyers committed to advancing diversity in the legal profession. It helps to unite the resources, energy and commitment of the state’s leading law firms, corporations, public sector entities, law schools, state and county bar associations and affinity bar organizations. The company was founded in 2003 and is headquartered in Hartford, CT. | Commercial Services |
